Capstone Therapeutics Corporation
05/06/2026 | Press release | Distributed by Public on 05/06/2026 05:30
Capstone Publishes Investor FAQ Detailing 72% Reduction in Convertible Principal and Reaffirming FY2026 Guidance (Form 8-K)
Capstone Publishes Investor FAQ Detailing 72% Reduction in Convertible Principal and Reaffirming FY2026 Guidance
FAQ details capital structure progress and operating outlook, including FY2026 guidance of $72.1M in revenue and approximately 322% EBITDA growth
NEW YORK--(BUSINESS WIRE)--Capstone Holding Corp. (NASDAQ: CAPS), a tech-enabled building products distribution platform, today published an investor FAQ on the Company's website detailing recent progress on its convertible debt, working capital facilities, and FY2026 outlook.
A key disclosure in the FAQ is that as of May 1, approximately 72% of the original convertible-note principal has been converted, leaving $1.90 million outstanding.
The FAQ addresses questions submitted by shareholders following the Company's April 16, 2026 earnings release and reaffirms the Company's FY2026 outlook: revenue of $72.1 million, up 54%; gross profit of approximately $18.7 million, up 73%; and EBITDA of approximately $3.8 million, an approximate 322% increase year-over-year. A positive EBITDA run-rate is expected beginning in Q2.
"We've heard the questions our shareholders are asking, and this FAQ answers them directly," said Matthew Lipman, Chief Executive Officer of Capstone. "We believe the capital structure is materially better than it was a year ago, and the operating business is materially larger. We expect both trends to continue."
Highlights from the FAQ:
|
1. |
Convertible Note Reduction: Of the $6.82 million in convertible-note principal originally issued in July and October 2025, approximately $4.92 million-or 72%-has been converted as of May 1, leaving $1.90 million outstanding. |
|
2. |
Working Capital Facility: At year-end 2025, Capstone had approximately $7.9 million drawn against its $11.5 million Beacon Bank & Trust revolver and was in compliance with all financial covenants, including Cash Flow Coverage and Tangible Net Worth requirements. Management is in active extension discussions and expects the facility to be extended. |
|
3. |
FY2026 Outlook Reaffirmed: $72.1 million revenue, ~$18.7 million gross profit, 26% gross margin, and approximately $3.8 million of EBITDA, with a positive EBITDA run-rate expected beginning in Q2. |
Access to Full Materials
The complete FAQ is available in the Investor Relations section of the Company's website at https://capstoneholdingcorp.com/capstone-faq-may-2026/. The Company's most recent Form 8-K filed with the Securities and Exchange Commission is available at sec.gov.
About Capstone Holding Corp.
Capstone Holding Corp. (NASDAQ: CAPS) is a national, technology-enabled building products distribution platform optimizing supply chains across 38 U.S. states and Canada. Through its Instone operating platform and inventory portal, the Company aggregates and delivers proprietary stone veneer, hardscape materials, and modular masonry systems. Capstone's model combines digital infrastructure, owned-inventory logistics, and disciplined acquisitions to drive scalable margin expansion and operating leverage across its growing platform.
Capstone Therapeutics Corporation published this content on May 06, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT) on May 06, 2026 at 11:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]